Группа авторов

Emergency Management of the Hi-Tech Patient in Acute and Critical Care


Скачать книгу

underlying disease process and potential for transplant, with many patients undergoing years of dialysis. Nearly 300 000 patients in the US have end‐stage renal disease, and more than 60% of these undergo hemodialysis. The vast majority of these patients are adults, with fewer than 1% of hemodialysis patients under age 20 years. In both pediatric and adult patients, however, complications of vascular access remain a significant source of morbidity and mortality.

      All forms of vascular access in hemodialysis allow blood to be pumped from the patient through the dialysis machine and back into the patient in a closed circuit. This circulation requires large‐caliber access for rapid circulation of patient's blood volume. There are several options for short‐ and long‐term vascular access in patients requiring hemodialysis.

      Hemodialysis Catheters

      These are large‐bore double lumen central venous catheters. Benefits of this type of access are that it can be placed rapidly and used immediately after placement and does not require any additional needle sticks for use. Drawbacks of this form of access include the risk of infection, potential for the catheter to become dislodged or removed inadvertently, and long‐term risk of vascular stenosis.

      Nontunneled hemodialysis catheter: This is a short‐term form of access that can be placed emergently for acute use or to bridge to a longer‐term access option. It is typically placed in the internal jugular (<3 weeks) or femoral veins (<5 days) and then stitched into place.

      Arterio‐Venous Access

Photo depicts tunneled catheter in deidentified patient.

      (Source: Photo credit Xenia Morgan.)

Photo depicts graft in situ.

      (Source: Photo credit Kimberly Windt.)

       Graft: This is a synthetic material that is surgically placed between an artery and a vein in the nondominant arm. It may be placed in a straight, looped, or curved configuration and is palpable under the skin. Gentle palpation will reveal a thrill. Maturation takes at least two weeks before it may be used (Figure 6.2).

       Fistula: This is a surgical connection of patient's native artery to native vein in nondominant arm. It will be palpable under the skin. Gentle palpation will reveal a thrill. Maturation takes one to four months.

      Hemodialysis may be used to replace renal function in acute and chronic renal failure. Some of the elements of renal function that may be controlled include the removal of naturally occurring metabolic waste products, regulation of acid–base status and electrolyte balance, regulation of intra‐ and extra‐vascular volume, and removal of toxic materials (e.g. after toxic ingestion).

      Hemodialysis Catheters

       Contact with the institution's or patient's renal and/or dialysis team is appropriate early during the patient's evaluation.

       Like all forms of central access, these devices should be handled by individuals trained in appropriate infection control and following the existing protocols of the home institution.

       Dressings vary by institution but may include a transparent dressing or one with a dry gauze component. Antiseptic and topical antibiotic use at exit site should conform to institutional policies.

       Note that catheters are locked with anticoagulant (e.g. high‐dose heparin, altepase, and citrate), and this must be removed prior to blood draws or instillation of medications (e.g. antibiotics) through the catheter. If not otherwise instructed by dialysis team, typically the volume removed should be three times the volume of the lumen (listed on the clamp of the device).

      Arterio‐venous Access

       Contact with the institution's or patient's renal and/or dialysis team is appropriate prior to access. In general, access should be avoided aside from dialysis procedure This site should not be used for blood draws, administration of medications, etc.

       Avoid any other intravenous access or needle sticks in the extremity; avoid taking blood pressures or constricting clothing on the extremity.

       Note that only gentle palpation of the site is appropriate; firm pressure may occlude blood flow.

      Hemodialysis Catheters

       Inability to draw blood from catheter: If the patient requires blood draw from the central access (e.g. in the setting of workup for fever) and clinician cannot draw from the lumen, contact the dialysis or renal team prior to attempting to flush. Recall that there is anticoagulant in the lumen which should not be flushed into patient without careful consideration. Conversation with renal or dialysis team will assist in planning appropriate approach.

       Hole or break in catheter: This should be treated, as with all compromise of central access, as a potential bloodstream infection. Cultures should be drawn, and the access should not be used pending repair or replacement by interventional radiology. Note that lab draws may be inaccurate for up to four hours after a dialysis session.

       Fever or evidence of exit site infection: Cultures should be drawn and antibiotics administered through both lumens of the catheter. Contact with renal and/or dialysis team will help direct therapy; in general, broad‐spectrum empiric antibiotic coverage is appropriate but review of prior culture data may further determine care. Note that lab draws may be inaccurate for up to four hours after a dialysis session.

       Displacement or migration of catheter: Displaced or migrated (for example, cuff is now visible outside of skin (as in Figure 6.3) catheters require replacement by interventional radiology. X‐ray may help determine the positioning of the catheter. Conversation with renal and/or dialysis team can determine urgency and protocol. Recall that this is a form of central access, and care should be used to apply appropriate pressure to stop bleeding.